Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.
作者信息
Yacoub Rabi, Nadkarni Girish N, Weikum Damian, Konstantinidis Ioannis, Boueilh Anna, Grant Robert M, Mugwanya Kenneth K, Baeten Jared M, Wyatt Christina M
机构信息
*Division of Nephrology, Department of Medicine, University at Buffalo, Buffalo, NY †Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY ‡Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT §Department of Nephrology-Transplantation-Dialysis, Bordeaux Hospital, Bordeaux, France ‖Gladstone Institutes, University of California, San Francisco and the San Francisco AIDS Foundation, San Francisco, CA ¶Department of Epidemiology, University of Washington, Seattle, WA #Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA.
出版信息
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e115-8. doi: 10.1097/QAI.0000000000000906.
Abstract
摘要
相似文献
1
Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e115-8. doi: 10.1097/QAI.0000000000000906.
2
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
Clin Infect Dis. 2017 Feb 1;64(3):317-325. doi: 10.1093/cid/ciw765. Epub 2016 Nov 15.
3
Pre-exposure prophylaxis is effective at preventing HIV in high risk gay men, study shows.
BMJ. 2015 Sep 10;351:h4860. doi: 10.1136/bmj.h4860.
4
Quantification of tenofovir disoproxil fumarate and emtricitabine in generic pre-exposure prophylaxis tablets obtained from the internet.
Int J STD AIDS. 2019 Jul;30(8):765-768. doi: 10.1177/0956462419841144. Epub 2019 May 9.
5
Risks and benefits HIV preexposure prophylaxis with tenofovir/emtricitabine in an older male with comorbidities.
AIDS. 2016 Aug 24;30(13):2131-3. doi: 10.1097/QAD.0000000000001171.
6
Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
Curr Opin HIV AIDS. 2016 Jan;11(1):49-55. doi: 10.1097/COH.0000000000000209.
7
Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.
Expert Opin Drug Saf. 2016;15(2):265-73. doi: 10.1517/14740338.2016.1128412. Epub 2015 Dec 23.
8
Acute Trigeminal Neuralgia Associated with Initiation of Emtricitabine/Tenofovir for HIV Pre-Exposure Prophylaxis.
J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218760846. doi: 10.1177/2325958218760846.
9
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
Drug Saf. 2017 Apr;40(4):273-283. doi: 10.1007/s40264-017-0505-6.
10
Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
Am Fam Physician. 2016 Mar 15;93(6):520.
引用本文的文献
1
Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in an Active-Duty Military Population.
AIDS Behav. 2025 Feb;29(2):607-612. doi: 10.1007/s10461-024-04543-4. Epub 2024 Nov 13.
2
Adverse effects of daily oral pre-exposure prophylaxis in men who have sex with men and transgender women: a systematic review and meta-analysis.
Cad Saude Publica. 2023 Dec 8;39Suppl 1(Suppl 1):e00089522. doi: 10.1590/0102-311XEN089522. eCollection 2023.
3
Pre-exposure prophylaxis for prevention of HIV infection.
Singapore Med J. 2023 Oct;64(10):624-628. doi: 10.4103/singaporemedj.SMJ-2022-018.
4
Retrospective audit of a convenience cohort of individuals on HIV pre-exposure prophylaxis in Alberta, Canada.
J Assoc Med Microbiol Infect Dis Can. 2022 Nov 29;7(4):350-363. doi: 10.3138/jammi-2022-0016. eCollection 2022 Nov.
5
Reasons for not using pre-exposure prophylaxis for HIV and strategies that may facilitate uptake in Ontario and British Columbia among gay, bisexual and other men who have sex with men: a cross-sectional survey.
CMAJ Open. 2023 Jun 27;11(3):E560-E568. doi: 10.9778/cmajo.20220113. Print 2023 May-Jun.
6
Pre-exposure prophylaxis for HIV: effective and underused.
CMAJ. 2022 Sep 6;194(34):E1164-E1170. doi: 10.1503/cmaj.220645.
7
Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda.
J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):174-181. doi: 10.1097/QAI.0000000000002434.
8
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.
Annu Rev Immunol. 2020 Apr 26;38:673-703. doi: 10.1146/annurev-immunol-080219-023629.
9
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.
Ann Intern Med. 2020 May 5;172(9):583-590. doi: 10.7326/M19-3478. Epub 2020 Mar 10.
10
HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
AIDS. 2020 Apr 1;34(5):699-706. doi: 10.1097/QAD.0000000000002456.
本文引用的文献
1
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
N Engl J Med. 2015 Feb 5;372(6):509-18. doi: 10.1056/NEJMoa1402269.
2
Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
JAMA Intern Med. 2015 Feb;175(2):246-54. doi: 10.1001/jamainternmed.2014.6786.
3
Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).
HIV Clin Trials. 2014 Nov-Dec;15(6):246-60. doi: 10.1310/hct1506-246.
4
Prevalence and European AIDS Clinical Society (EACS) criteria evaluation for proximal renal tubular dysfunction diagnosis in patients under antiretroviral therapy in routine setting.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19564. doi: 10.7448/IAS.17.4.19564. eCollection 2014.
5
Renal function of participants in the Bangkok tenofovir study--Thailand, 2005-2012.
Clin Infect Dis. 2014 Sep 1;59(5):716-24. doi: 10.1093/cid/ciu355. Epub 2014 May 14.
6
Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.
PLoS One. 2014 Mar 20;9(3):e92717. doi: 10.1371/journal.pone.0092717. eCollection 2014.
7
HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
Lancet Infect Dis. 2014 Jun;14(6):468-75. doi: 10.1016/S1473-3099(14)70025-8. Epub 2014 Mar 7.
8
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.
AIDS. 2014 Mar 27;28(6):851-9. doi: 10.1097/QAD.0000000000000156.
9
Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials.
PLoS One. 2014 Feb 3;9(2):e87674. doi: 10.1371/journal.pone.0087674. eCollection 2014.
10
Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.
AIDS. 2013 Aug 24;27(13):2155-60. doi: 10.1097/QAD.0b013e3283629037.
Zotero 插件